EverSource Wealth Advisors »

Zentalis Pharmaceuticals shares owned by EverSource Wealth Advisors

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by EverSource Wealth Advisors from 13F filings

Historical chart of EverSource Wealth Advisors investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by EverSource Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by EverSource Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $10k 3.4k 3.03
2024-09-30 $12k 3.3k 3.68
2024-06-30 $11k 2.8k 3.89
2024-03-31 $18k 1.6k 11.06
2023-12-31 $16k 1.0k 15.15
2023-09-30 $2.8k 141 20.06
2023-06-30 $4.0k 141 28.21

More positions owned by EverSource Wealth Advisors

Vanguard Growth Etf Etf (VUG)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Value Etf Etf (VTV)
Apple Stock (AAPL)
iShares Gold Trust ETF Etf (IAU)
Vanguard S&p 500 Etf Etf (VOO)
Tesla Stock (TSLA)
Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Fidelity Wise Origin Bitcoin Fund Etf (FBTC)
Microsoft Corp Stock (MSFT)
Nvidia Corporation Stock (NVDA)
Amazon Stock (AMZN)
Sovereigns Capital Flourish Fund Etf (SOVF)
Vanguard Dividend Appreciation Etf Etf (VIG)
Vanguard Short-term Bond Etf Etf (BSV)

View all positions for EverSource Wealth Advisors

Top funds holding Zentalis Pharmaceuticals

Matrix Capital Management Company
Eventide Asset Management
BlackRock
Vanguard Group
Citadel Advisors
Decheng Capital
Opaleye Management
Morgan Stanley
Almitas Capital
PRIMECAP Management Company
Geode Capital Management
State Street Corporation
D. E. Shaw & Co
Verition Fund Management
MPM Oncology Impact Management

View all funds holding Zentalis Pharmaceuticals